Arkolith/Insider Trading/RGNX/Form 4

Karabelas Argeris N

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Sep 4, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2024Option exercise(M)10K$3.76$38K21K
Sep 3, 2024Sell(S)700$12.34$9K11K
Sep 3, 2024Sell(S)9K$11.50$107K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 3, 2024Option exercise(M)10K—$010K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML